What anti‑anxiety medication would be appropriate for a patient with worsening anxiety who is currently taking primidone for essential tremor and high‑dose propranolol?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 3, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Anti-Anxiety Medication Selection in a Patient on Primidone and High-Dose Propranolol

Start with an SSRI—specifically escitalopram or sertraline—as first-line pharmacotherapy for anxiety in this patient, as propranolol is ineffective for generalized anxiety disorders and should not be relied upon for anxiety management. 1, 2, 3

Critical Context: Propranolol Does Not Treat Anxiety Disorders

  • Canadian Clinical Practice Guidelines specifically deprecate the use of beta-blockers (including propranolol) for anxiety disorders based on negative evidence. 2
  • A 2025 systematic review and meta-analysis found no evidence for beneficial effects of beta-blockers compared with placebo in patients with social phobia or panic disorder (p ≥0.54 for all comparisons). 3
  • While propranolol may help with performance anxiety or situational tremor exacerbation, it does not address underlying anxiety pathophysiology. 2, 3

First-Line SSRI Recommendations

Escitalopram is the preferred initial choice due to:

  • Fewer drug-drug interactions compared to other SSRIs 1
  • First-line status per American Academy of Child and Adolescent Psychiatry guidelines 1
  • Lower risk of discontinuation syndrome than paroxetine or fluvoxamine 4, 1

Sertraline is an equally appropriate alternative:

  • Listed as first-line pharmacotherapy in multiple guidelines 4
  • Requires monitoring for discontinuation syndrome (though less than paroxetine) 1

Dosing Strategy

  • Start with a subtherapeutic "test" dose to assess for initial anxiety or agitation that can occur when starting SSRIs 4
  • Increase gradually at 1-2 week intervals for shorter half-life SSRIs like sertraline or escitalopram 1
  • Expect clinically significant improvement by week 6, with maximal improvement by week 12 or later 4

Important Drug Interaction Considerations with Primidone

  • Primidone itself can cause or worsen anxiety, depression, and mood changes per FDA labeling. 5
  • The FDA warns that primidone may cause "new or worsening anxiety" as a side effect, which complicates the clinical picture 5
  • Primidone can interact with other medications, requiring careful monitoring when adding SSRIs 5
  • Do not abruptly discontinue primidone if considering medication adjustments, as this can cause status epilepticus 5

Second-Line Options If SSRIs Fail

Venlafaxine extended-release (SNRI) 75-225 mg/day:

  • Strong international consensus as standard pharmacotherapy with efficacy equal to SSRIs 2
  • Number needed to treat (NNT) of 4.94 for anxiety disorders 4
  • Critical monitoring requirement: blood pressure must be checked regularly due to risk of sustained hypertension 2

Pregabalin:

  • Recommended as first-line by Canadian Clinical Practice Guidelines 2
  • Particularly advantageous if comorbid pain conditions exist 2
  • Works through a different mechanism (antiepileptic analog) when SSRIs/SNRIs fail 2

Benzodiazepines: Limited Role

Alprazolam may be considered for intermittent use only:

  • A 2000 study showed alprazolam was equipotent to primidone for tremor control at mean dose 0.75 mg daily 6
  • Can be used during periods when anxiety causes functional disability 7, 8
  • Not recommended for chronic daily use due to dependence risk
  • Clonazepam is an alternative benzodiazepine option 7, 8

Mandatory Combination with CBT

  • Cognitive behavioral therapy (CBT) must be offered alongside any medication, as combination therapy provides superior outcomes to medication alone. 1, 2
  • Structured treatment should include approximately 14 individual sessions over 4 months, with each session lasting 60-90 minutes 4, 2
  • Individual CBT is prioritized over group therapy due to superior clinical and cost-effectiveness 2

Monitoring Requirements

  • Systematically assess treatment response using standardized symptom rating scales 4
  • Monitor for suicidal ideation, particularly given primidone's FDA black box warning about increased suicide risk with antiepileptic drugs 5
  • Watch for serotonin syndrome if combining SSRIs with other serotonergic agents—requires 14-day washout from MAOIs 4
  • Be vigilant for discontinuation syndrome symptoms: dizziness, fatigue, headaches, nausea, insomnia, and paradoxical anxiety 4, 1

Common Pitfalls to Avoid

  • Do not assume the high-dose propranolol is adequately treating anxiety—it is not effective for anxiety disorders. 2, 3
  • Do not use paroxetine as first-line due to higher discontinuation syndrome risk and increased suicidal thinking compared to other SSRIs. 4, 1
  • Avoid concomitant MAOIs with any SSRI due to serotonin syndrome risk 4
  • Do not use quetiapine, levetiracetam, or tricyclic antidepressants—these have negative evidence for anxiety 2
  • Recognize that primidone itself may be contributing to worsening anxiety per FDA labeling 5

References

Guideline

First-Line Medications for Anxiety

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Non-SSRI Medications for Social and Attachment Anxiety

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Treatment Options for Anxiety After Fluoxetine Failure

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

New alternative agents in essential tremor therapy: double-blind placebo-controlled study of alprazolam and acetazolamide.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 2000

Research

Medical treatment of essential tremor.

Journal of central nervous system disease, 2014

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.